SNAL News

It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain Atour Lifestyle Holdings (ATAT). Two small issuers also slipped through the IPO window despite increased scrutiny from regulators....read more

Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two SPACs submitted initial filings. In the pipeline, large IPOs KinderCare Learning Companies (KLC),...read more

Snail, a developer and publisher of online multiplayer games for various platforms, raised $15 million by offering 3 million shares at $5, within the range of $4 to $6. The company originally planned to offer 5 million shares at a range of $5 to $7 before lowering the terms last month. Snail is an independent developer and publisher of interactive digital entertainment, with a...read more

Snail, a developer and publisher of online multiplayer games for various platforms, lowered the proposed deal size for its upcoming IPO on Wednesday. The Culver City, CA-based company now plans to raise $15 million by offering 3 million shares at a price range of $4 to $6. The company had previously filed to offer 5 million shares at a range of $5 to $7. At the midpoint of the...read more